Advertisement

Topics

EMA's Pharmacovigilance and Risk Assessment Committee elects Sabine Straus as new Chair from Sept 2018

17:01 EDT 13 Jul 2018 | PharmaBiz

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) at its July 2018 meeting elected Sabine Straus from the Netherlands as its new Chair, for a three─year mandate

Original Article: EMA's Pharmacovigilance and Risk Assessment Committee elects Sabine Straus as new Chair from Sept 2018

NEXT ARTICLE

More From BioPortfolio on "EMA's Pharmacovigilance and Risk Assessment Committee elects Sabine Straus as new Chair from Sept 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...